Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TOBRAMYCIN

Ingredient

TOBRAMYCIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TOBI	300MG	SOLUTION	Resolved	2021-12-23	2022-01-13	151871
TOBI PODHALER	28MG	CAPSULE	Resolved	2024-09-03	2025-01-29	236492
TOBI PODHALER	28MG	CAPSULE	Resolved	2025-11-04	2026-03-09	271073
TOBI PODHALER	28MG	CAPSULE	Resolved	2025-10-28	2025-11-04	270450
TOBI PODHALER	28MG	CAPSULE	Resolved	2025-05-21	2025-10-20	257939
TOBI PODHALER	28MG	CAPSULE	Resolved	2025-02-25	2025-05-15	251246
TOBI PODHALER	28MG	CAPSULE	Avoided shortage	2025-02-18	2025-02-25	250630
TOBI PODHALER	28MG	CAPSULE	Resolved	2020-03-17	2020-04-22	108834
TOBI PODHALER	28MG	CAPSULE	Resolved	2025-01-29	2025-02-12	249040
TOBRADEX	0.1% 0.3%	OINTMENT	Resolved	2017-09-18	2017-11-02	22359

Previous
1
2
3
4
5
…
8
Next

Showing 21 to 30 of 71

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TOBRAMYCIN INHALATION SOLUTION	300MG	SOLUTION	Discontinued	2021-09-02	2021-09-02	145015
TOBRAMYCIN INJECTION, USP	40MG	SOLUTION	Discontinued	2022-01-12	2022-01-12	152485

1

Showing 1 to 2 of 2